We are monitoring the impact of COVID-19 on APAC Diabetes Care Devices Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 83
Share on
Share on

Asia Pacific Diabetes Care Devices Market Research Report - Segmented By Device Type And Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, And Forecast (2020 to 2025)

Pulished: February, 2020
ID: 83
Pages: 145

APAC Diabetes Care Devices Market Size (2020 to 2025)

The size of the Diabetes Care Devices Market in the Asia Pacific was estimated at USD 2.75 Billion in 2020. It is expected to reach USD 3.93 billion by 2025, at a CAGR of 7.41% during the forecast period from 2020 to 2025.

Diabetes is a group of metabolic disorders, chronic condition which is associated with an abnormally high level of sugar (glucose) in the blood. Southeast Asia currently witnesses 78.3 million people affected with Diabetes, which is going to reach 140.2 million by 2040. Western Pacific region witnesses 153.2 million people affected with diabetes, and this number is said to reach 214.8 million by 2040.

The Asia Pacific has the highest diabetes population, with the number increasing at quite an alarming rate. Due to this, there is a massive demand for diabetes care devices, primarily driving the market. Also, the increasing healthcare costs operate the market with increased revenues accumulated by the companies in this region.

But the market growth is constrained here due to low medical literacy rate, leading to the fall in sales of devices.

This research report on the APAC Insulin Delivery Devices Market has been segmented and sub-segmented into the following categories:

  • By Type: Insulin Syringes, Insulin Pens, Insulin Pen Needles, Insulin Pumps And Insulin Jet Injectors
  • By Application: Type I Diabetes and Type II Diabetes
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and rest of the Asia Pacific

Regionally, countries like China, India, Japan, Korea, and Australia. China and India are the leading contributors in this region with a significant incidence of companies involved in manufacturing diabetes care devices, due to the highest prevalence of Diabetes population in their areas. China has the world’s largest community, with close to 1.4 billion people, followed by India, with around 1.2 billion people in 2014. According to the International Diabetes Federation, China had the most significant number of diabetic patients, with about 96.2 million diabetic patients followed by India, with around 66.8 million diabetic patients in 2014. It represents a majority of approximately 40-45% of the global diabetic population living in India and China, providing significant opportunities for the global diabetes care devices companies to invest in this region.

Leading companies operating in the APAC Diabetes Care Devices Market profiled in this report are Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Ascensia, Tandem, and Terumo.

Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 Global Diabetes Care Devices Market, by Type                                                           

                                5.1.1 Glucose Monitoring Devices                                            

                                                5.1.1.1 Self Blood Glucose Monitoring Devices                   

                                                                5.1.1.1.1 Glucose Meters             

                                                                5.1.1.1.2 Test strips        

                                                                5.1.1.1.3 Lancets              

                                                                5.1.1.1.4 Hemoglobin A1c testing Kits     

                                                5.1.1.2 Continous Glucose Monitoring Devices                  

                                5.1.2 Insulin Delivery Systems                                   

                                                5.1.2.1 Insulin Syringes                 

                                                5.1.2.2 Insulin Pens                        

                                                5.1.2.3 Insulin Pumps                    

                                                5.1.2.4 Jet Injectors                        

                                5.1.3 Control Solutions                                  

  1. Geographical Analysis

                6.3 Asia-Pacific                                                 

                                6.1 Introduction                                               

                                6.2 China                                             

                                6.3 India                                              

                                6.4 Japan                                            

                                6.5 South Korea                                               

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 F. Hoffmann-La Roche Ltd                                                    

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Medtronic Inc.                                                          

                8.3 Johnson & Johnson                                                 

                8.4 Abbott Laboratories                                                               

                8.5 Becton, Dickinson and Company                                                       

                8.6 Ascensia Diabetes care                                                          

                8.7 Novo Nordisk A/S                                                    

                8.8 Dexcom, Inc.                                                              

                8.9 Insulet Corporation                                                 

                8.10 Terumo Corporation                                                            

                8.11 Tandem Diabetes Care, Inc                                               

                8.12 Ypsomed AG                                                           

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Diabetes Care Devices Market, By Type from 2020 to 2025 (USD Million)
  2. Asia-Pacific Glucose Monitoring Devices Market, By Region from 2020 to 2025 (USD Million)
  3. Asia-Pacific Glucose Monitoring Devices Market, By Type from 2020 to 2025 (USD Million)
  4. Asia-Pacific Self Monitoring Blood Glucose (SMBG) Market, By Region from 2020 to 2025 (USD Million)
  5. Asia-Pacific Continuous Glucose Monitoring (CGM) Devices Market, By Region from 2020 to 2025 (USD Million)
  6. Asia-Pacific Self Monitoring Blood Glucose (SMBG) Market, By Type from 2020 to 2025 (USD Million)
  7. Asia-Pacific Glucose Meters Market, By Region from 2020 to 2025 (USD Million)
  8. Asia-Pacific Testing Strips Market, By Region from 2020 to 2025 (USD Million)
  9. Asia-Pacific Lancets Market, By Region from 2020 to 2025 (USD Million)
  10. Asia-Pacific Haemoglobin A1C Testing Kits Market, By Region from 2020 to 2025 (USD Million)
  11. Asia-Pacific Insulin Delivery Devices Market, By Region from 2020 to 2025 (USD Million)
  12. Asia-Pacific Insulin Delivery Devices Market, By Type from 2020 to 2025 (USD Million)
  13. Asia-Pacific Insulin Syringes Market, By Region from 2020 to 2025 (USD Million)
  14. Asia-Pacific Insulin Pumps Market, By Region from 2020 to 2025 (USD Million)
  15. Asia-Pacific Insulin Pens Market, By Region from 2020 to 2025 (USD Million)
  16. Asia-Pacific Insulin Jet Injectors Market, By Region from 2020 to 2025 (USD Million)
  17. Asia-Pacific Control Solutions Market, By Region from 2020 to 2025 (USD Million)
  18. Asia-Pacific Diabetes Care Devices Market, By Region from 2020 to 2025 (USD Million)
  19. Asia-Pacific Diabetes Care Devices Market, By Region from 2020 to 2025 (USD Million)
  20. Asia-Pacific Diabetes Care Devices Market, By Type from 2020 to 2025 (USD Million)
  21. Asia-Pacific Glucose Monitoring Devices Market, By Type from 2020 to 2025 (USD Million)
  22. Asia-Pacific Self Monitoring Blood Glucose (SMBG) Market, By Type from 2020 to 2025 (USD Million)
  23. Asia-Pacific Insulin Delivery Devices Market, By Type from 2020 to 2025 (USD Million)
  24. China Diabetes Care Devices Market, By Type from 2020 to 2025 (USD Million)
  25. China Glucose Monitoring Devices Market, By Type from 2020 to 2025 (USD Million)
  26. China Self Monitoring Blood Glucose (SMBG) Market, By Type from 2020 to 2025 (USD Million)
  27. China Insulin Delivery Devices Market, By Type from 2020 to 2025 (USD Million)
  28. India Diabetes Care Devices Market, By Type from 2020 to 2025 (USD Million)
  29. India Glucose Monitoring Devices Market, By Type from 2020 to 2025 (USD Million)
  30. India Self Monitoring Blood Glucose (SMBG) Market, By Type from 2020 to 2025 (USD Million)
  31. India Insulin Delivery Devices Market, By Type from 2020 to 2025 (USD Million)
  32. Japan Diabetes Care Devices Market, By Type from 2020 to 2025 (USD Million)
  33. Japan Glucose Monitoring Devices Market, By Type from 2020 to 2025 (USD Million)
  34. Japan Self Monitoring Blood Glucose (SMBG) Market, By Type from 2020 to 2025 (USD Million)
  35. Japan Insulin Delivery Devices Market, By Type from 2020 to 2025 (USD Million)
  36. South Korea Diabetes Care Devices Market, By Type from 2020 to 2025 (USD Million)
  37. South Korea Glucose Monitoring Devices Market, By Type from 2020 to 2025 (USD Million)
  38. South Korea Self Monitoring Blood Glucose (SMBG) Market, By Type from 2020 to 2025 (USD Million)
  39. South Korea Insulin Delivery Devices Market, By Type from 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample